Stockscreener 앱 받기
95.76
0.90%
0.85
시간 외 거래:
95.76
Dianthus Therapeutics Inc 주식(DNTH)의 최신 뉴스
Dianthus Therapeutics shares jump 25% after encouraging clinical trial update - MSN
Strength seen in Dianthus Therapeutics, Inc. (DNTH): Can its 5.6% jump turn into more strength? - MSN
Dianthus Therapeutics CFO Sells $9.5 Million in Stock - AOL.com
Dianthus Therapeutics (NASDAQ:DNTH) Sets New 1-Year HighShould You Buy? - MarketBeat
Dianthus Therapeutics EVP Sells $10M in Shares - National Today
SG Americas Securities LLC Invests $765,000 in Dianthus Therapeutics, Inc. $DNTH - MarketBeat
DNTH SEC FilingsDianthus Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Dianthus Therapeutics (NASDAQ:DNTH) EVP Ryan Savitz Sells 8,224 Shares - MarketBeat
Ryan Savitz, Dianthus Therapeutics CFO, sells $738k in DNTH stock - Investing.com Canada
Dianthus Therapeutics Insider Sold Shares Worth $738,844, According to a Recent SEC Filing - marketscreener.com
Dianthus (NASDAQ: DNTH) CFO exercises options, sells 8,224 shares under 10b5-1 plan - Stock Titan
Dianthus Therapeutics Upgraded to Strong Buy at Wolfe Research - National Today
Dianthus Therapeutics (NASDAQ:DNTH) Upgraded by Wolfe Research to "Strong-Buy" Rating - MarketBeat
Dianthus Therapeutics stock hits 52-week high at 90.2 USD By Investing.com - Investing.com Australia
Ryan Savitz files Form 144 to sell 8,224 shares (NASDAQ: DNTH) - Stock Titan
Dianthus Therapeutics (DNTH) details 2026 director, pay and auditor votes - Stock Titan
Dianthus Therapeutics stock hits 52-week high at 90.2 USD - Investing.com
Wolfe Research Begins Coverage on Dianthus Therapeutics (NASDAQ:DNTH) - MarketBeat
Dianthus Therapeutics (NASDAQ:DNTH) Sets New 12-Month HighTime to Buy? - MarketBeat
Can Dianthus Therapeutics Inc expand into new marketsEarnings Growth Report & Low Risk High Reward Ideas - baoquankhu1.vn
Dianthus Therapeutics, Inc.Common Stock (DNTH) Stock Price, News, Quote & History - FinancialContent
Dianthus Therapeutics Announces Inducement Grants - National Today
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Dianthus Therapeutics CFO Sells $9.5 Million in Stock - The Motley Fool
JPMorgan Chase & Co. Has $2.68 Million Stock Position in Dianthus Therapeutics, Inc. $DNTH - MarketBeat
Dianthus gives 8 new employees stock options at $84.56 a share - Stock Titan
Aug Momentum: Can Dianthus Therapeutics Inc expand into new markets2026 Retail Activity & AI Enhanced Trading Alerts - baoquankhu1.vn
Dianthus Therapeutics, Inc. (DNTH) stock price, news, quote and history - Yahoo Finance UK
A Look At Dianthus Therapeutics (DNTH) Valuation After A Strong Year Of Share Price Gains - Sahm
Wedbush keeps outperform on Dianthus Therapeutics, Inc. (DNTH), highlights potential of Claseprubart in CIDP - MSN
Dianthus Therapeutics EVP Sells Over $9 Million in Shares - National Today
How Investors May Respond To Dianthus Therapeutics (DNTH) Early “GO” Decision And FDA Backing For Claseprubart - Yahoo Finance
Dianthus Therapeutics (NASDAQ:DNTH) EVP Sells $9,492,461.00 in Stock - MarketBeat
Dianthus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Wells Fargo Remains a Buy on Dianthus Therapeutics (DNTH) - The Globe and Mail
Dianthus Therapeutics(DNTH.US) Officer Sells US$9.49 Million in Common Stock - Moomoo
Dianthus Therapeutics stock hits 52-week high at 88.35 USD By Investing.com - Investing.com Australia
Dianthus therapeutics director Soteropoulos sells $47985 in stock By Investing.com - Investing.com Australia
Dianthus therapeutics director Soteropoulos sells $47985 in stock - Investing.com
Savitz of Dianthus sold $9.5m in DNTH stock - Investing.com UK
Savitz of Dianthus sold $9.5m in DNTH stock By Investing.com - Investing.com South Africa
Dianthus Therapeutics Insider Sold Shares Worth $9,492,596, According to a Recent SEC Filing - marketscreener.com
Dianthus Therapeutics (DNTH) CFO exercises options, sells 114,367 shares - Stock Titan
Dianthus Therapeutics (DNTH) director exercises options then sells 599 shares - Stock Titan
Dianthus Therapeutics (NASDAQ:DNTH) Sets New 52-Week HighTime to Buy? - MarketBeat
Dianthus Therapeutics stock hits 52-week high at 88.35 USD - Investing.com
2.69%
0.25%
자본화:
|
볼륨(24시간):